SCHEMBL2013176

SCHEMBL2013176

CN(C(=O)c1cc(Cl)nc2ccccc12)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.59
HCRTR2 O43614 2/20 0.59
RAB9A P51151 3/20 0.45
NPC1 O15118 2/20 0.45
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.39
MAPT P10636 3/20 0.39
RXFP1 Q9HBX9 2/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 2/20 0.39
USP2 O75604 1/20 0.39
MEN1 O00255 3/20 0.39
UBE2N P61088 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013226 1.00 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2017894 0.91 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2052571 0.91 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2011290 0.89 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2011288 0.89 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2049210 0.87 HCRTR1 (0.68) HCRTR1HCRTR2RAB9ANPC1
SCHEMBL2013519 0.87 HCRTR1 (0.68) HCRTR1HCRTR2RAB9ANPC1
SCHEMBL2054308 0.86 HCRTR1 (0.60) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2011844 0.86 HCRTR1 (0.60) HCRTR1HCRTR2RAB9ANPC1KMT2A
SCHEMBL2015340 0.86 HCRTR1 (0.57) HCRTR1HCRTR2RAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed